
Join to view full profile
100 Blossom StHematology Oncology Associates Cox 2Boston, MA 02114
Phone+1 617-724-3200
Fax+1 617-726-2894
Dr. Boussiotis is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UMass Chan Medical SchoolResidency, Internal Medicine, 2004 - 2004
University of AthensClass of 1982
Certifications & Licensure
MA State Medical License 2004 - 2028
Clinical Trials
Publications & Presentations
PubMed
- 4 citationsSame-Slide Spatial Multiomics Integration with IN-DEPTH Reveals Tumor Virus-Linked Spatial Reorganization of the Tumor Microenvironment.Stephanie Pei Tung Yiu, Yuzhou Chang, Yao Yu Yeo, Huaying Qiu, Wenrui Wu
Cancer Discovery. 2026-08-03 - A new twist in metabolic T cell exhaustion.Konstantinos Aliazis, Vassiliki A Boussiotis
Immunometabolism. 2026-04-01 - 27 citationsMulti-scaled transcriptomics of chronically inflamed nasal epithelium reveals immune-epithelial dynamics and tissue remodeling in nasal polyp formation.Guanrui Liao, Tsuguhisa Nakayama, Bokai Zhu, Ivan T Lee, Jason Yeung
Immunity. 2025-10-14
Press Mentions
NanoView Biosciences Launches EPIC Study to Investigate Impact of Exosome-Associated Biomarkers for Immuno-OncologyApril 15th, 2021
NanoView, Beth Israel Deaconess Medical Center Launch Immuno-Oncology Biomarker StudyApril 15th, 2021
CD39+PD-1+CD8+ T Cells Mediate Metastatic Dormancy in Breast CancerFebruary 3rd, 2021
Grant Support
- Navigating Pathways of Innate Immunity and Epigenetic Memory in Checkpoint ImmunotherapyBETH ISRAEL DEACONESS MEDICAL CENTER2025–2032
- Dissecting Orchestrated Immune Responses to Glioblastoma within the Native Tissue Microenvironment to Improve Treatment OutcomesBETH ISRAEL DEACONESS MEDICAL CENTER2025–2030
- Understanding the cellular and functional changes in the immune tumor microenvironment of glioblastoma during progression and treatments.BETH ISRAEL DEACONESS MEDICAL CENTER2023–2028
- Detection of PD-1 inhibitory signaling and its molecular relays in T cells: Implications for cancer immunotherapyBETH ISRAEL DEACONESS MEDICAL CENTER2023–2027
- The effects of PD-1 on tumor-mediated “emergency” myelopoiesis and fate commitment of myeloid cells: Implications for anti-tumor immunityBETH ISRAEL DEACONESS MEDICAL CENTER2020–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: